ID
42794
Description
Study part: Demographics Screening . A Phase IIIb, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of Ranibizumab In Subjects With Subfoveal Choroidal Neovascular (CNV) With Or Without Classic CNV Secondary To Age-Related Macular Degeneration.
Keywords
Versions (2)
- 2/22/18 2/22/18 -
- 9/17/21 9/17/21 -
Copyright Holder
Roche
Uploaded on
September 17, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Demographics Screening Ranibizumab Age-Related Macular Degeneration FVF3192g
Similar models
Demographics Screening
- StudyEvent: ODM
C2986440 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)